| BF2-azadipyrromethene NIR-emissive fluorophores with research and clinical potential HC Daly, G Sampedro, C Bon, D Wu, G Ismail, RA Cahill, DF O'Shea European Journal of Medicinal Chemistry 135, 392-400, 2017 | 51 | 2017 |
| Structure activity relationship studies on rhodanines and derived enethiol inhibitors of metallo-β-lactamases D Zhang, MS Markoulides, D Stepanovs, AM Rydzik, A El-Hussein, C Bon, ... Bioorganic & Medicinal Chemistry 26 (11), 2928-2936, 2018 | 23 | 2018 |
| A Fluorescence‐Based Assay for Screening β‐Lactams Targeting the Mycobacterium tuberculosis Transpeptidase LdtMt2 M de Munnik, CT Lohans, GW Langley, C Bon, J Brem, CJ Schofield ChemBioChem 21 (3), 368-372, 2020 | 15 | 2020 |
| Procainamide–SAHA Fused Inhibitors of hHDAC6 Tackle Multidrug-Resistant Malaria Parasites F Nardella, L Halby, I Dobrescu, J Viluma, C Bon, A Claes, ... Journal of Medicinal Chemistry 64 (14), 10403-10417, 2021 | 10 | 2021 |
| Bisubstrate inhibitors: the promise of a selective and potent chemical inhibition of epigenetic ‘writers’ C Bon, L Halby, PB Arimondo Epigenomics 12 (17), 1479-1482, 2020 | 7 | 2020 |
| Targeting DOT1L for mixed-lineage rearranged leukemia C Bon, Y Si, PB Arimondo Histone Modifications in Therapy, 81-99, 2020 | 6 | 2020 |
| Synthesis and biological activity of a cytostatic inhibitor of MLLr leukemia targeting the DOT1L protein C Bon, Y Si, M Pernak, M Barbachowska, E Levi-Acobas, V Cadet Daniel, ... Molecules 26 (17), 5300, 2021 | 5 | 2021 |
| A novel screening strategy to identify histone methyltransferase inhibitors reveals a crosstalk between DOT1L and CARM1 Y Si, C Bon, M Barbachowska, V Cadet-Daniel, C Jallet, L Soresinetti, ... RSC Chemical Biology 3 (4), 456-467, 2022 | 4 | 2022 |
| Chemical targeting of DNA and histone methylation in cancer: Novelties, hopes and promises C Bon, D Erdmann, L Halby, PB Arimondo Bulletin du Cancer 106 (10), 823-833, 2019 | 2 | 2019 |
| Étude d'un photochrome de la famille des diaryléthènes J Piard, R Métivier, PA Payard, F Volatron Le Bulletin de l'Union des Professeurs de Physique et de Chimie 111 (993 …, 2017 | 2 | 2017 |
| Synthèse et détermination de la taille de nanoprismes d'argent J Piard, S Zimmer, G Chupin, C Bon, Y Cheref, E Cazayus-Claverie Le Bulletin de l'Union des Professeurs de Physique et de Chimie 110 (988 …, 2016 | 2 | 2016 |
| Late‐Stage Aryl C− H Bond Cyclopropenylation with Cyclopropenium Cations HF Tu, A Jeandin, C Bon, C Brocklehurst, F Lima, MG Suero Angewandte Chemie 135 (36), e202308379, 2023 | 1 | 2023 |
| Identification of Chemical Probes Targeting MBD2 D Erdmann, J Contreras, RA Le Meur, B Vitorge, V Saverat, A Tafit, ... ACS Chemical Biology 17 (6), 1415-1426, 2022 | 1 | 2022 |
| Espoirs et promesses de la méthylation de l’ADN et des histones comme cibles anticancéreuses C Bon, D Erdmann, L Halby, PB Arimondo Bulletin du Cancer 106 (10), 823-833, 2019 | 1 | 2019 |
| Thermoluminochromisme de complexes de type Cu4I4(pyridine)4 RMR Jonathan Piard, Corentin Bon, Celine Jegat, Clement Doré, Christina ... Bulletin de l'union des physicien 111 (991), 205-224, 2017 | 1* | 2017 |
| Synthèse et étude d’un cristal liquide cholestérique : fabrication d’un thermomètre AB Jonathan Piard, Valérie Genot, Corentin Bon, Yannis Cheref Bulletin de l'union des physicien 109 (984), 661-685, 2016 | 1* | 2016 |
| MicroCycle: An Integrated and Automated Platform to Accelerate Drug Discovery CE Brocklehurst, E Altmann, C Bon, H Davis, D Dunstan, P Ertl, ... Journal of Medicinal Chemistry, 2024 | | 2024 |
| Quinazoline-based analog of adenine as an antidote against MLL-rearranged leukemia cells: synthesis, inhibition assays and docking studies C Bon, M Barbachowska, N Djokovic, D Ruzic, Y Si, L Soresinetti, C Jallet, ... Future Medicinal Chemistry 14 (8), 557-570, 2022 | | 2022 |
| Direct Synthesis of Allyl Amines with 2‐Nitrosulfonamide Derivatives via the Tsuji‐Trost Reaction C Bon, PB Arimondo, L Halby ChemistryOpen 10 (12), 1166-1169, 2021 | | 2021 |
| Conception et synthèse d'une chimiothèque ciblée contre les épi-méthyltransférases C Bon Université Paris Cité, 2021 | | 2021 |
Ludovic HalbyCNRS/PasteurAdresse e-mail validée de cnrs.fr
